Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Running, not enrolling

Conditions studied: Cancer, Cancer (With or Without Metastasis)

In brief

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Key facts

Study ID

NCT07107607

Run by

HealthPartners Institute

People needed

50

Starts

2021-03-19

Expected to finish

2027-01-01

Last updated by the study team

2026-05-07

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• diagnosed with cancer
• have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer
• believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

You may not qualify if…

• does not have cancer
• has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
• does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Where it is running

• HealthPartners Institute Cancer Research Center — Saint Louis Park, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.